Data / Form D filings / Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc.: Form D filings
Kinaset Therapeutics, Inc., a pharmaceuticals company in Medfield, MA, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on July 17, 2023, reports $28.5 million sold of a $41 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10 KNOLLWOOD ROAD, Medfield, MA, 02052
- Phone
- (508) 858-5810
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1821223
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 17, 2023 | Amendment | $41,000,000 | $28,500,000 | $12,500,000 | 3 | Jul 5, 2022 | sec.gov |
| Jul 18, 2022 | New notice | $41,000,000 | $28,500,000 | $12,500,000 | 3 | Jul 5, 2022 | sec.gov |
| Aug 17, 2020 | New notice | $40,000,000 | $1,500,000 | $38,500,000 | 3 | Jul 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tom King | Director | |
| Jamil Beg | Director | |
| Robert Clarke | Executive Officer, Director, Promoter | |
| Bram Vanparys | Director | |
| Frazer Morgan | Executive Officer, Promoter | |
| Kevin Bitterman | Director | |
| Roger Heerman | Executive Officer, Promoter |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jul 17, 2023 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Kinaset Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.